Skórka, K.; Wdowiak-Filip, A.; Stasiak, G.; Bartosińska, J.; Krasowska, D.; Giannopoulos, K.
Aberrant Expression of BTLA, CD160, SPN, TIM-3, VISTA and TIGIT in Chronic Lymphocytic Leukemia and Psoriasis Patients Compared to Healthy Volunteers. Cancers 2025, 17, 2116.
https://doi.org/10.3390/cancers17132116
AMA Style
Skórka K, Wdowiak-Filip A, Stasiak G, Bartosińska J, Krasowska D, Giannopoulos K.
Aberrant Expression of BTLA, CD160, SPN, TIM-3, VISTA and TIGIT in Chronic Lymphocytic Leukemia and Psoriasis Patients Compared to Healthy Volunteers. Cancers. 2025; 17(13):2116.
https://doi.org/10.3390/cancers17132116
Chicago/Turabian Style
Skórka, Katarzyna, Anita Wdowiak-Filip, Grażyna Stasiak, Joanna Bartosińska, Dorota Krasowska, and Krzysztof Giannopoulos.
2025. "Aberrant Expression of BTLA, CD160, SPN, TIM-3, VISTA and TIGIT in Chronic Lymphocytic Leukemia and Psoriasis Patients Compared to Healthy Volunteers" Cancers 17, no. 13: 2116.
https://doi.org/10.3390/cancers17132116
APA Style
Skórka, K., Wdowiak-Filip, A., Stasiak, G., Bartosińska, J., Krasowska, D., & Giannopoulos, K.
(2025). Aberrant Expression of BTLA, CD160, SPN, TIM-3, VISTA and TIGIT in Chronic Lymphocytic Leukemia and Psoriasis Patients Compared to Healthy Volunteers. Cancers, 17(13), 2116.
https://doi.org/10.3390/cancers17132116